For designers of targeted drugs, the biggest bullseye in prostate cancer has been the androgen receptor — a specialized net on prostate cells that snares androgen molecules to spur the cells’ growth. Drugs that block, or inhibit, the receptor can halt the cancer, but not all patients benefit from them, and nearly all those who … Continued
Early on an October morning, Shaun Tierney started a promising new treatment for his stage IV kidney cancer. Anxious to tell his longtime oncologist, he texted Toni Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana-Farber. What he didn’t expect was that Choueiri would have his own big news: “Kaelin … Nobel … Continued
There was a time when Bradley McGregor, MD, had what many would consider an unusual morning routine for an oncologist. Getting ready for work included putting on nearly 60 pounds of body armor, donning a tactical helmet, and grabbing his assault rifle before heading out the door. His commute took him from an American compound, … Continued
When he was 67 years old, Barry Polsky said “I do” for the first time in his life when he married his wife, Randi. One year later, the retired high school teacher and lifelong baseball fan was offered one of his dream jobs as a tour guide at Fenway Park. And earlier this year, at … Continued
African-Americans have a 60 percent higher incidence of prostate cancer compared to other ethnic groups, and a 150 percent higher risk of dying from it — in part because blacks tend to have a more aggressive form. They are also more likely to develop prostate cancer at an earlier age and to have a more … Continued
Medically reviewed by Bradley McGregor, MD Kidney cancer occurs when the cells of the kidney acquire abnormal mutations in their DNA and then multiply. These cells may accumulate and form a tumor; in some cases, they metastasize and spread elsewhere in the body. Can I inherit kidney cancer? A family history of kidney cancer does … Continued
Medically reviewed by Himisha Beltran, MD Prostate cancer, when diagnosed early, can be a very treatable disease. Even advanced prostate cancer has treatment options. But some advanced, metastatic prostate cancers become resistant to standard therapies by shapeshifting into a different type of cancer, called small cell neuroendocrine prostate cancer. These neuroendocrine tumors tend to be … Continued
Cancer is often fueled by hormones, including the male sex hormone testosterone, which spur tumor growth in most forms of prostate cancer. Doctors can defuse this destructive relationship, typically with drugs (or sometimes surgery), but frequently, the tumors adapt or evolve, devising ways to incite cancer growth even in the absence of hormone-driven signals. These … Continued
Urinary problems are more common among older adults, when incontinence and urinary-tract infections become more prevalent and bladder cancer risk rises. About 9 out of 10 bladder cancer patients are above the age of 55, according to the American Cancer Society. The symptoms of bladder cancer can mirror those of other conditions, so it’s important … Continued
Carcinoma of the prostate is a type of prostate cancer that occurs when normal prostate cells begin to grow uncontrollably. Carcinomas begin in the epithelial tissue—the thin tissue, like skin, that covers the linings of internal organs. Other cancers typically form in the body’s connective or supportive tissues (sarcomas), blood-forming tissue like bone marrow (leukemia), … Continued
Leigh Ellis, PhD, once seemed destined for a career intercepting passes as a professional rugby player. Now, the Dana-Farber researcher is devising plays to intercept prostate cancer cells before they become metastatic. These tactics could also potentially slow other genitourinary diseases, including kidney cancer. Ellis’ laboratory works to better understand the underlying genetic and epigenetic … Continued
Prostate cancer is a disease that forms in the tissues of the prostate, a male gland just below the bladder which is partly responsible for making the fluid that is part of semen. Prostate cancer forms within cells in the prostate. The disease takes a variable course from patient to patient. Some prostate cancers spread … Continued
As father and daughter, there are many things Dennis Gorden and Becky Nutley share: a contagious smile, the instinct to help others, and a commitment to family, to name a few. But one thing they never imagined they would have in common was a cancer diagnosis. In 2014, routine blood work revealed that Becky Nutley, … Continued
Benign prostate hyperplasia (BPH) is a common condition among men in their 60s and 80s that is caused by an enlargement of the prostate. Conflicting research poses speculation as to whether BPH actually leads to prostate cancer. Here, Mark Pomerantz, MD, a medical oncologist at Dana-Farber Cancer Institute who specializes in treating prostate cancer, clarifies … Continued
Prostate cancer is a disease in which cancer forms in the prostate, a gland located just below the bladder and in front of the rectum in males. In the United States, a man has a one in five chance of being diagnosed with this disease in his lifetime. But there are still a lot of … Continued
The past two years have seen striking changes in how advanced bladder cancer is treated.
A recent discovery about prostate cancer suggests potential new targeted therapeutic strategies for this disease.
Dana-Farber’s Toni Choueiri, MD, will participate in his first Pan-Mass Challenge (PMC) bike-a-thon in August. “Considering his dedication to me and his other patients, I am not surprised that he is riding in the PMC and raising money to develop new treatments for people with my type of kidney cancer,” says a former patient of Choueiri’s.
Long-term studies of men with low-risk prostate cancer have demonstrated that active surveillance is safe and that a majority of patients can successfully forego surgery or radiation for over 10 years.